Source: USPQ, 2d Series (1986 - Present) > U.S. Court of Appeals, Federal Circuit > Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., 94 USPQ2d 1161 (Fed. Cir. 2010)…
1. Significant U.S. Cases in 2010 Brian R. Dorn, Ph.D. November 4, 2010 2. Cases Bilski v. Kappos Ariad v. Eli Lilly & Co . ACLU v. USPTO(“Myriad”) Daiichi Sankyo…
Slide 1Ariad v. Eli Lilly 560 F.3d 1366 (Fed. Cir. 2009) Written Description as a Function of Enablement N. Scott Pierce, Esq. Suffolk University Law School November 4, 2009…
Slide 1September 21, 2006 DePaul University, Chicago, IL APLF- DePaul University College of Law 2006 Symposium on Intellectual Property Law Slide 2 Alicia Alvarez Berkenwald,…
Project Management An Introduction Overview Background Project Management Definition and purpose Elements of Project Management Ensuring a project is successful Project management…
Slide 1 Experimental Data to Support Patentability of a Biological Pharmaceutical in the U.S. October 14, 2011 Presented by M. Paul Barker 1 Slide 2 Agenda Utility Requirement…
Slide 1 ENABLEMENT / WRITTEN DESCRIPTION PATENT PROSECUTION PRACTICE Presented at: Webb & Co. Rehovot, Israel Date: February 21, 2013 Presented by: Roy D. Gross Associate…